Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality

Med J Aust. 2009 Aug 17;191(4):199-200. doi: 10.5694/j.1326-5377.2009.tb02752.x.

Abstract

Large-scale randomised controlled trials in Europe and the United States are informing evidence-based clinical advice.

Publication types

  • Editorial

MeSH terms

  • Aged
  • Europe / epidemiology
  • Evidence-Based Medicine*
  • Humans
  • Male
  • Mass Screening*
  • Middle Aged
  • Prostate-Specific Antigen / analysis*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / mortality
  • Randomized Controlled Trials as Topic*
  • Uncertainty*
  • United States / epidemiology

Substances

  • Prostate-Specific Antigen